Analysts Applaud Covid-19 Treatment’s Positive Data - BitcoinEthereumNews.com
अर्थव्यवस्थाविश्लेषकों ने कोविद -19 उपचार के सकारात्मक डेटा की सराहना की07 / 11 / 2022बिटकॉइन एथेरियम समाचार The market might be exhibiting undeniable bearish trends all year, but there are always exceptions to the rule. One such name that has been defying the downward pull is Veru (Veru). The shares have added 140% year-to-date with the past week providing the latest leg up. Investors have been getting behind the potential of the companys Covid-19 treatment, sabizabulin; and last week, data published in the New England Journal of Medicine (NEJM) showed decidedly positive results from a phase 3 clinical study of the drug. Patients who received sabizabulin as opposed to a placebo showed a 55.2% relative decrease in mortality, a 26% relative decrease in hospital days, and a 43% relative decrease in intensive care unit days. Additionally, the adverse effect profile of the drug was determined to be adequate, supporting the findings from earlier clinical trials. That said, following the datas release, short-seller Culper Research had a bone to pick with the results, claiming that at trial entry, there was an imbalance in oxygenation status, which gave an advantage to the sabizabulin group vs. the placebo cohort. However, Oppenheimer analyst लेलैंड गेरशेल believes that is not